These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 23707305

  • 21. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E, Ruegger M, Dunne I, Sutaria N, Towers WF.
    Am J Health Syst Pharm; 2023 Sep 07; 80(18):1238-1246. PubMed ID: 37335862
    [Abstract] [Full Text] [Related]

  • 22. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.
    Watson M, Abbott KC, Yuan CM.
    Clin J Am Soc Nephrol; 2010 Oct 07; 5(10):1723-6. PubMed ID: 20798253
    [Abstract] [Full Text] [Related]

  • 23. [Effect of ion exchange resins on the composition of milk].
    Bonnet L, Goudable J, Accominotti M, Fontaine D, Cochat P.
    Nephrologie; 1997 Oct 07; 18(7):287-9. PubMed ID: 9496569
    [Abstract] [Full Text] [Related]

  • 24. Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake.
    Bunchman TE, Wood EG, Schenck MH, Weaver KA, Klein BL, Lynch RE.
    Pediatr Nephrol; 1991 Jan 07; 5(1):29-32. PubMed ID: 2025533
    [Abstract] [Full Text] [Related]

  • 25. Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia.
    Batterink J, Lin J, Au-Yeung SH, Cessford T.
    Can J Hosp Pharm; 2015 Jan 07; 68(4):296-303. PubMed ID: 26327703
    [Abstract] [Full Text] [Related]

  • 26. Treatment of infant formula with patiromer dose dependently decreases potassium concentration.
    Paloian NJ, Bowman B, Bartosh SM.
    Pediatr Nephrol; 2019 Aug 07; 34(8):1395-1401. PubMed ID: 30963285
    [Abstract] [Full Text] [Related]

  • 27. Growth and biochemical response of preterm infants fed human milk or modified infant formula.
    Gross SJ.
    N Engl J Med; 1983 Feb 03; 308(5):237-41. PubMed ID: 6848932
    [Abstract] [Full Text] [Related]

  • 28. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT.
    Can J Kidney Health Dis; 2020 Feb 03; 7():2054358120965838. PubMed ID: 33240515
    [Abstract] [Full Text] [Related]

  • 29. [Case report of an infant hyperkalemia: Suggestion of a hospital procedure for the milk pretreatment with sodium polystyrene sulfonate resin].
    Robert S, Nisse YE, Henn-Ménétré S, Vrillon I, Demoré B.
    Ann Pharm Fr; 2020 Jul 03; 78(4):287-293. PubMed ID: 32439127
    [Abstract] [Full Text] [Related]

  • 30. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.
    Hasara S, Dubey J, Amatea J, Finnigan N.
    Am J Emerg Med; 2023 Mar 03; 65():59-64. PubMed ID: 36586223
    [Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of two potassium cocktail formulations for treatment of neonatal hyperkalemia.
    Oschman A, Gansen A, Kilbride H, Sandritter T.
    Ann Pharmacother; 2011 Nov 03; 45(11):1371-7. PubMed ID: 22009997
    [Abstract] [Full Text] [Related]

  • 32. Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia.
    Yoo N, Song YB, Dubinsky I, Altshuler J.
    Ann Pharmacother; 2023 Sep 03; 57(9):1044-1052. PubMed ID: 36637028
    [Abstract] [Full Text] [Related]

  • 33. Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice.
    Le Palma K, Pavlick ER, Copelovitch L.
    Clin Kidney J; 2018 Apr 03; 11(2):166-171. PubMed ID: 29644055
    [Abstract] [Full Text] [Related]

  • 34. Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients.
    Yu MY, Yeo JH, Park JS, Lee CH, Kim GH.
    PLoS One; 2017 Apr 03; 12(3):e0173542. PubMed ID: 28328954
    [Abstract] [Full Text] [Related]

  • 35. Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study.
    Pergola PE, Spiegel DM, Warren S, Yuan J, Weir MR.
    Am J Nephrol; 2017 Apr 03; 46(4):323-332. PubMed ID: 29017162
    [Abstract] [Full Text] [Related]

  • 36. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
    Kim HJ.
    Nephron; 1996 Apr 03; 72(3):476-82. PubMed ID: 8852501
    [Abstract] [Full Text] [Related]

  • 37. Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors.
    Weir MR, Bushinsky DA, Benton WW, Woods SD, Mayo MR, Arthur SP, Pitt B, Bakris GL.
    Am J Med; 2018 May 03; 131(5):555-564.e3. PubMed ID: 29180023
    [Abstract] [Full Text] [Related]

  • 38. Effect of phosphate or magnesium cathartics on serum calcium: observations in normocalcemic patients.
    Wiberg JJ, Turner GG, Nuttall FQ.
    Arch Intern Med; 1978 Jul 03; 138(7):1114-6. PubMed ID: 666471
    [Abstract] [Full Text] [Related]

  • 39. Glucose and insulin infusion versus kayexalate for the early treatment of non-oliguric hyperkalemia in very-low-birth-weight infants.
    Hu PS, Su BH, Peng CT, Tsai CH.
    Acta Paediatr Taiwan; 1999 Jul 03; 40(5):314-8. PubMed ID: 10910540
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of potassium binders in the treatment of patients with chronic kidney disease and hyperkalemia.
    Dong L, Xu W, Deng Y, Tan J, Qin W.
    Eur J Pharmacol; 2022 Sep 15; 931():175174. PubMed ID: 35964658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.